71 related articles for article (PubMed ID: 2443093)
1. Bay k 8644, a calcium entry promoter, as an antidote in verapamil intoxication in rabbits.
Korstanje C; Jonkman FA; Van Kemenade JE; Van Zwieten PA
Arch Int Pharmacodyn Ther; 1987 May; 287(1):109-19. PubMed ID: 2443093
[TBL] [Abstract][Full Text] [Related]
2. New treatment methods in verapamil poisoning: experimental studies.
Magdalan J
Pol J Pharmacol; 2003; 55(3):425-32. PubMed ID: 14506322
[TBL] [Abstract][Full Text] [Related]
3. The effects of 4-aminopyridine and Bay K 8644 on verapamil-induced cardiovascular toxicity in anesthetized rats.
Tuncok Y; Apaydin S; Gelal A; Ates M; Guven H
J Toxicol Clin Toxicol; 1998; 36(4):301-7. PubMed ID: 9711195
[TBL] [Abstract][Full Text] [Related]
4. Biphasic dose-response relationship observed with Bay k 8644 on atrioventricular nodal conduction inhibited by verapamil.
Lang J; Timour Q; Lançon JP; Aupetit JF; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):196-201. PubMed ID: 2460775
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of verapamil intoxication with 4-aminopyridine in the cat.
Agoston S; Maestrone E; van Hezik EJ; Ket JM; Houwertjes MC; Uges DR
J Clin Invest; 1984 May; 73(5):1291-6. PubMed ID: 6538884
[TBL] [Abstract][Full Text] [Related]
6. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
[TBL] [Abstract][Full Text] [Related]
7. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
8. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
Taira N; Wada Y; Satoh K
J Pharmacol Exp Ther; 1985 Jan; 232(1):244-50. PubMed ID: 2578189
[TBL] [Abstract][Full Text] [Related]
9. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
Graudins A; Najafi J; Rur-SC MP
Clin Toxicol (Phila); 2008 Jan; 46(1):50-6. PubMed ID: 17926153
[TBL] [Abstract][Full Text] [Related]
11. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
Schramm M; Thomas G; Towart R; Franckowiak G
Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
[TBL] [Abstract][Full Text] [Related]
12. [Central cardiovascular effects of a calcium inhibitor, nifedipine, and a calcium channel activator, Bay k 8644, in the anesthetized rat].
Girerd X; Laurent S; Tsoukaris-Kupfer D; Schmitt H
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):923-8. PubMed ID: 2432847
[TBL] [Abstract][Full Text] [Related]
13. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of high dosages of verapamil and the lack of protection by 4-aminopyridine in the rabbit.
Wesseling H; Houwertjes MC; de Langen CD; Kingma JH
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):106-12. PubMed ID: 6667060
[TBL] [Abstract][Full Text] [Related]
15. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
16. Opposite central cardiovascular effects of nifedipine and BAY k 8644 in anesthetized rats.
Tsoukaris-Kupfer D; Girerd X; Laurent S; Legrand M; Huchet-Brisac AM; Schmitt H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S40-3. PubMed ID: 2455137
[TBL] [Abstract][Full Text] [Related]
17. Protective activity of calcium entry blockers against ouabain intoxication in anesthetized guinea pigs.
Jonkman FA; Boddeke HW; van Zwieten PA
J Cardiovasc Pharmacol; 1986; 8(5):1009-13. PubMed ID: 2429073
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176.
Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC
J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of somatostatin inhibition of calcium influx in the anterior pituitary cell line AtT-20.
Reisine T
J Pharmacol Exp Ther; 1990 Aug; 254(2):646-51. PubMed ID: 1696631
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
Young W; Chen J; Jung F; Gardner P
Mol Pharmacol; 1988 Sep; 34(3):239-44. PubMed ID: 2458520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
